Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 07 - 13 tags : Drug save search
QSAM Biosciences Receives Third U.S. Patent for Clinical-Stage Radiopharmaceutical Drug Candidate CycloSam®
Published: 2022-07-13 (Crawled : 18:00) - globenewswire.com
QSAM | $8.14 -31.58% 3.2K
|
Manufacturing
| Email alert
Add to watchlist
cyclosam drug patent candidate
Enveric Biosciences Advances Drug Development for Mental Health Indications and Intellectual Property Portfolio
Published: 2022-07-13 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: -2.06%
ENVB | $0.938 4.52% 4.33% 180K
|
Health Technology
|
| O: 3.52%
H: 10.42%
C: 0.71%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.38%
H: 0.0%
C: 0.0%
drug health
AVROBIO Receives Orphan Drug Designation from the U.S. Food and Drug Administration for AVR-RD-05, a Gene Therapy for Mucopolysaccharidosis Type II (MPSII) or Hunter Syndrome
Published: 2022-07-13 (Crawled : 12:00) - biospace.com/
AVRO | $1.195 -1.24% -1.26% 350K
|
Health Technology
|
| O: 2.37%
H: 3.08%
C: -1.22%
rd-05 designation drug food therapy avr-rd-05 mps-ih
Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Vast Potential in Cell Therapy, Disease Modelling, Drug Development and Discovery, Personalized Medicine & Toxicology Testing
Published: 2022-07-13 (Crawled : 12:00) - prnewswire.com
CTXR | $0.7199 -6.18% -6.58% 880K
|
Health Technology
|
| O: -1.6%
H: 4.79%
C: 1.9%
drug disease report potential market
3D Printed Drugs Market to be Worth $269.74 Million by 2030: Grand View Research, Inc.
Published: 2022-07-13 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -0.1%
H: 0.05%
C: -1.41%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -1.62%
H: 0.83%
C: 0.37%
market drug
U.S. Alliance Pharma Acquires U.K.-based LGC’s Drug Development Solutions (DDS) Business
Published: 2022-07-13 (Crawled : 11:00) - biospace.com/
KKR | $96.77 -1.23% 1.44% 3.6M
|
Finance
|
| O: -2.19%
H: 2.25%
C: 1.14%
pharma drug solutions
Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU
Published: 2022-07-13 (Crawled : 07:00) - biospace.com/
RLFTF | $1.45 11.45% 1.3K
|
n/a
|
| O: -14.17%
H: 21.5%
C: 15.26%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -1.41%
H: 0.0%
C: 0.0%
treatment drug acquire approved agreement
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.